WHWK · Whitehawk Therapeutics
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Market Cap
183M
52 Wk Range
$1.97 - $5.50
Previous Close
$3.25
Open
$3.23
Volume
222,609
Day Range
$3.08 - $3.26
Enterprise Value
86.33M
Cash
190M
Avg Qtr Burn
-14.53M
Insider Ownership
12.62%
Institutional Own.
81.06%
Qtr Updated
Jun 30th 2026
